Insider Trading: AngioDynamics Inc (ANGO.O)
ANGO.O on Nasdaq
10.68USD
17 May 2013
10.68USD
17 May 2013
Price Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$10.68
$10.68
Open
$10.73
$10.73
Day's High
$10.73
$10.73
Day's Low
$10.57
$10.57
Volume
58,979
58,979
Avg. Vol
120,716
120,716
52-wk High
$12.91
$12.91
52-wk Low
$9.52
$9.52
All Insider Trades
| Trading Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| 24 Mar 2013 | GOLD JEFFREY G |
Director | Buy | 2,508 | $6.52 |
| 11 Mar 2013 | BUCCI VINCENT A |
Director | Buy | 35,000 | $10.76 |
| 11 Mar 2013 | BUCCI VINCENT A |
Director | Buy | 40,000 | $10.78 |
| 11 Mar 2013 | METENY DENNIS S |
Director | Buy | 4,600 | $10.82 |
| 11 Mar 2013 | BUCCI VINCENT A |
Director | Buy | 10,000 | $10.80 |
| 13 Feb 2013 | BUCCI VINCENT A |
Director | Buy | 2,000 | $12.17 |
| 31 Jan 2013 | FROST MARK T |
Chief Financial Officer | Buy | 20,000 | $0.00 |
| 27 Jan 2013 | MCGILL STEPHEN J |
Officer | Sell | 2,600 | $12.35 |
| 27 Jan 2013 | STARK RICHARD |
Officer | Sell | 838 | $12.35 |
| 10 Jan 2013 | GOULD KEVIN J |
Director | Buy | 2,700 | $11.58 |
| 16 Dec 2012 | BOURNE GEORGE W IV |
Chief Operating Officer | Buy | 2,000 | $0.00 |
| 14 Nov 2012 | KAPUSTA MATTHEW C |
Officer | Sell | 1,358 | $10.12 |
| 4 Nov 2012 | STARK RICHARD |
Officer | Sell | 3,160 | $10.36 |
| 4 Nov 2012 | GOLD JEFFREY G |
Director | Buy | 1,000 | $10.56 |
| 22 Oct 2012 | SOTO JOHN |
Officer | Buy | 10,000 | $0.00 |
| 6 Sep 2012 | DEVIVO JOSEPH |
Chief Executive Officer | Sell | 2,526 | $12.12 |
| 3 Sep 2012 | GERSUK D JOSEPH |
Chief Financial Officer | Sell | 1,086 | $11.61 |
| 3 Sep 2012 | STARK RICHARD |
Officer | Sell | 715 | $11.61 |
| 16 Aug 2012 | DEVIVO JOSEPH |
Chief Executive Officer | Buy | 22,247 | $0.00 |
| 16 Aug 2012 | MCGILL STEPHEN J |
Officer | Buy | 15,000 | $0.00 |
| 16 Aug 2012 | PANZER ALAN |
Officer | Buy | 7,500 | $0.00 |
| 16 Aug 2012 | STARK RICHARD |
Officer | Buy | 10,000 | $0.00 |
| 16 Aug 2012 | ETLINGER RICHARD SCOTT |
Officer | Buy | 6,500 | $0.00 |
| 16 Aug 2012 | GERSUK D JOSEPH |
Chief Financial Officer | Buy | 12,000 | $0.00 |
| 16 Aug 2012 | KAPUSTA MATTHEW C |
Officer | Buy | 5,000 | $0.00 |
Institutional Holders
| % Shares Owned: | 94.97% |
| # of Holders: | 114 |
| Total Shares Held: | 33,286,770 |
| 3 Mo. Net Change: | -279,538 |
| # New Positions: | 17 |
| # Closed Positions: | 9 |
| # Increased Positions: | 52 |
| # Reduced Positions: | 39 |
| # Net Buyers: | 13 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Vincent Bucci |
57 | 2007 | Independent Chairman of the Board |
Joseph DeVivo |
45 | 2011 | President, Chief Executive Officer, Director |
Mark Frost |
49 | 2013 | Chief Financial Officer, Executive Vice President |
George Bourne |
52 | 2012 | Senior Vice President, Chief Technology & Operations Officer |
Stephen McGill |
51 | 2009 | Senior Vice President, General Manager - International |
Alan Panzer |
51 | 2012 | Senior Vice President, General Manager - US Sales |
Matthew Kapusta |
40 | 2011 | Senior Vice President - Business Development |
Louis Mazzarese |
2012 | Senior Vice President, Chief Regulatory Officer | |
John Soto |
2012 | Senior Vice President - Global Franchise, Peripheral Vascular | |
Richard Stark |
47 | 2012 | Senior Vice President - Global Franchise, Oncology/Surgery |
Charles Greiner |
45 | 2012 | Vice President - Global Franchise, Vascular Access |
David Burgstahler |
44 | 2012 | Independent Director |
Howard Donnelly |
51 | 2004 | Independent Director |
Jeffrey Gold |
64 | 1997 | Independent Director |
Kevin Gould |
58 | 2010 | Independent Director |
Wesley Johnson |
54 | 2007 | Independent Director |
Steven LaPorte |
62 | 2007 | Independent Director |
Dennis Meteny |
59 | 2004 | Independent Director |
Sriram Venkataraman |
40 | 2012 | Independent Director |
Gregory Gin |
IR Contact Officer |

